The occurrence and development of cancer involves the participation of many factors, its pathological mechanism is far more complicated than other diseases, and the treatment is also extremely difficult. Although the treatment of cancer adopts diversified methods to improve the survival rate and quality of life of patients, but the drug resistance, metastasis and recurrence of cancer cause most patients to fail in treatment. Therefore, exploring new molecular targets in cancer pathology is of great value for improving and preventing the treatment of cancer. Fortunately, the P2Y2 purinergic receptor (P2Y2 receptor) in the G protein-coupled receptor family has been recognized for regulating cancer progression. Agonist activated P2Y2 receptor has a certain contribution to the growth and metastasis of tumor cells. P2Y2 receptor activation participates in cancer progression by regulating calcium ion channels and classical signaling pathways (such as PLC-PKC and PI3K/AKT). It has the effect of anti-tumor therapy by inhibiting the activation of P2Y2 receptor (the use of antagonist) and reducing its expression. Therefore, in this article, we focus on the expression patterns of P2Y2 receptor in cancer and potential pharmacological targets as anti-cancer treatments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.abb.2024.110194 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Activation of Purinergic P2Y2 Receptor Protects the Kidney Against Renal Ischemia and Reperfusion Injury in Mice.
Int J Mol Sci
November 2024
Department of Pharmacology, Institute of Medical Sciences, College of Medicine, Gyeongsang National University, Jinju 52727, Republic of Korea.
Extracellular ATP plays an important role in renal physiology as well as the pathogenesis of acute kidney injury induced by renal ischemia and reperfusion (IR). Expression of the purinergic P2Y2 receptor has been shown on inflammatory and structural cells of the kidney, and P2Y2R is preferably activated by ATP (or UTP). Here, we investigated the molecular mechanism of P2Y2R during IR injury by using P2Y2R knockout (KO) mice and a selective P2Y2R agonist, MRS2768.
View Article and Find Full Text PDFGlia-like taste cells mediate an intercellular mode of peripheral sweet adaptation.
Cell
November 2024
School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea; The Institute of Molecular Biology and Genetics, Seoul 08826, Republic of Korea. Electronic address:
The sense of taste generally shows diminishing sensitivity to prolonged sweet stimuli, referred to as sweet adaptation. Yet, its mechanistic landscape remains incomplete. Here, we report that glia-like type I cells provide a distinct mode of sweet adaptation via intercellular crosstalk with chemosensory type II cells.
View Article and Find Full Text PDFG protein coupled P2Y2 receptor as a regulatory molecule in cancer progression.
Arch Biochem Biophys
December 2024
Urology Department, The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang City, China. Electronic address:
The occurrence and development of cancer involves the participation of many factors, its pathological mechanism is far more complicated than other diseases, and the treatment is also extremely difficult. Although the treatment of cancer adopts diversified methods to improve the survival rate and quality of life of patients, but the drug resistance, metastasis and recurrence of cancer cause most patients to fail in treatment. Therefore, exploring new molecular targets in cancer pathology is of great value for improving and preventing the treatment of cancer.
View Article and Find Full Text PDFP2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior.
Purinergic Signal
October 2024
Metastasis Molecular Mechanisms Laboratory and Neurosciences Laboratory, Institute of Chemistry, Biochemistry Department, University of Sao Paulo, Sao Paulo, Brazil.
Tumor-associated macrophages (TAMs) exhibit antitumor or protumor responses related to inflammatory (or M1) and alternative (or M2) phenotypes, respectively. The P2X7 receptor plays a key role in macrophage polarization, influencing inflammation and immunosuppression. In this study, we investigated the role of the P2X7 receptor in TAMs.
View Article and Find Full Text PDFPurinergic signaling in liver disease: calcium signaling and induction of inflammation.
Purinergic Signal
September 2024
Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, USA.
Article Synopsis
- * Abnormal calcium signaling caused by specific purinergic receptors (like P2X7 and certain P2Y receptors) can disrupt normal liver cell functions and activate other liver cells, leading to immune responses associated with liver damage and fibrosis.
- * Targeting purinergic receptors with pharmacological interventions may offer new treatment options for liver conditions by modulating calcium signaling and reducing complications like hepatic steatosis and fibrosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!